Hartmut Link

发表

A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer.

T. Gauler, P. Martus, K. Caca, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

P. Schőffski, G. Folprecht, S. Al-Batran, 2008, British Journal of Cancer.

Capecitabine (Cape) versus 5-fluorouracil (5-FU)-based (neo)adjuvant chemoradiotherapy (CRT) for locally advanced rectal cancer (LARC): Long-term results of a randomized, phase III trial.

S. Post, F. Wenz, R. Hofheinz, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.